Concepedia

Advanced glycated end-products (AGE) during haemodialysis treatment: discrepant results with different methodologies reflecting the heterogeneity of AGE compounds

Thomas Henle, Reinhold Deppisch, Werner Beck, Olaf Hergesell, G.M. Hänsch, Eberhard Ritz

Nephrology Dialysis Transplantation · 1999 · 124 citations · 23 references

DOIFull text

Open access

Abstract

High-flux dialysis reduces the plasma concentration of fluorescent AGE compounds, i.e. pentosidine, but the Amadori product fructoselysine is not removed, indicating that this compound is protein associated.

References

23

Advanced oxidation protein products as a novel marker of oxidative stress in uremia

Véronique Witko‐Sarsat, Miriam A. Friedlander, Chantal Capeillère‐Blandin et al. · Kidney International · 1996 · 2K citations · Full text

, , +10

Structure Elucidation of a Senescence Cross-Link from Human Extracellular Matrix

David R. Sell, Vincent M. Monnier · Journal of Biological Chemistry · 1989 · 1.1K citations · Full text

Advanced Glycosylation End Products in Patients with Diabetic Nephropathy

Zenji Makita, Steven Radoff, Elliot J. Rayfield et al. · New England Journal of Medicine · 1991 · 921 citations · Full text

Orally absorbed reactive glycation products (glycotoxins): An environmental risk factor in diabetic nephropathy

T Koschinsky, Cijiang He, Tomoko Mitsuhashi et al. · Proceedings of the National Academy of Sciences · 1997 · 784 citations · Full text

New Aspects of the Maillard Reaction in Foods and in the Human Body

Franz Ledl, Erwin Schleicher · Angewandte Chemie International Edition in English · 1990 · 732 citations

, , +22